HCM (HUTCHMED Ltd) Aset Perusahaan

HUTCHMED (China) Limited (HCM) management is successfully launching oncology drugs into global markets, and the company's assets by ROA on the current GURU.Markets chart contain data where 1756.86 becomes the new value of the indicator. This confirms the business's independence from economic cycles, as demand for therapy remains stable, strengthening the brand's status as a powerful innovator in Asia.

HCM - Total Aset Perusahaan HUTCHMED Ltd ing rentang 04.07.2022 - 31.10.2026

Rincian metrik keuangan lan pasar HUTCHMED Ltd (HCM)

- rega pasar lan target rega analis:

Bagan kurs hutch-med.com|HCM - Prakiraan konsensus analis

- indikator valuasi pasar bisnis:

Nilai pasar HUTCHMED Corp|HCM - Nilai Total Perusahaan

- data ekuitas miturut neraca:

Ekuitas saben Saham HUTCHMED|HCM - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku hutch-med.com|HCM - Aset Agregat Perusahaan

- rincian utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi HUTCHMED (China) Limited|HCM - Utang jangka dawa marang modal|Utang jangka cendhak marang modal HUTCHMED Corp|HCM - Utang perusahaan|Rasio utang marang kapitalisasi buku HUTCHMED Corp|HCM - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan HUTCHMED|Likuiditas darurat hutch-med.com

- statistik bathi lan rasio pasar:

HCM - Bathi resik perusahaan

Analisis dhasar perusahaan:hutch-med.com, HCM

Total assets, which have reached 1756.86, determine the financial stability of the issuer through the sum of all resources and liabilities, calculated reversely based on daily ROA. By analyzing the total asset trends of the enterprise, an investor can assess the ability of HUTCHMED (China) Limited (HCM) to scale its oncology portfolio in the US and China, where the growth of the resource base directly correlates with the commercial success of new drugs.

Pesaing wigati